Top Image
Advanced Centre for Treatment Research & Education in Cancer
Facebook Twitter Gmail
Banner Image
Science Sparks @ ACTREC
Date Image 20th November 2023 Vol. No. 12; Issue No. 605
Publications

1. Chichra A, Nayak L, Kothari R, Kalantri S, Bonda A, Gokarn A, Punatar S, Mirgh S, Jindal N, Bagal B, Kannan S, Mathew L, Khattry N (2023). Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis. International Journal of Hematology.

2. Ranganathan S, Dee EC, Debnath N, Patel TA, Jain B, Murthy V. Access and barriers to genomic classifiers for breast cancer and prostate cancer in India. International Journal of Cancer.

3. Rajput N. Mapping cancer in India: Implementing GIS for cancer research and registries. Indian Journal of Cancer. 60(3): 293-294.

Site of the Week

MetaboLights is a database for Metabolomics experiments and derived information.The database is cross-species, cross-technique and covers metabolite structures.

 desktop Image
Interesting Reads

Mandour YM, Refaat E, Hassanein HD (2023). Anticancer activity, phytochemical investigation and molecular docking insights of Citrullus colocynthis (L.) fruits. Scientific Reports. 13: 20038.

Video of the Week
2023 Jeffrey M. Trent Lecture in Cancer Research: Perspectives of Cancer Precision Medicine
Upcoming Events
19th National Research Scholars Meet - NRSM

December 7 - 8, 2023

At ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai.
12th Eurpoean congress on Breast Cancer, Womens Health and Therapeutics

December 7 - 9, 2023

At Dubai, UAE
RNA Modifications in Health and Disease.

December 12 - 15, 2023

At Fairmont Banff Springs, Alberta, Canada
Do You Know?

In 1952, Epidemiologists at the American Cancer Society launched the Hammond-Horn Study, a long-term follow-up study of 188,000 men designed to examine the association of cigarette smoking with death from cancer and other diseases.

 back Image
Cancer News
Discovery of an antibody that stimulates the immune system to eliminate cancer cells.

MedicalXpress, 16/11/2023

The researchers developed a new antibody, named Z10, that frees SLAMF7 from CD47, thereby augmenting elimination of tumor cells. When combined with other agents Z10 is highly effective against cancer cells expressing SLAMF7, at least in mice…
Scientists identify T-cell differentiation nodes to improve cancer killing.

ScienceDaily, 15/11/2023

Scientists mapped the gene regulatory networks responsible for progressive differentiation states of tumor-infiltrating T cells, using a technology known as single-cell CRISPR screening to knock out or genetically perturb multiple genes potentially involved
Selpercatinib slows progression of RET-positive lung, medullary thyroid cancers.

National Cancer Institute, 15/11/2023

The new trial provided evidence that selpercatinib can shrink tumors in the brain in people with NSCLC. Twenty-nine participants in the trial had measurable brain metastases. During the study, these metastases shrank in 82% of those who received selpercatinib, compared with 58% of those who received chemotherapy...

2019 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)